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shoot the breeze. Second, if not for developing Parkinson’s, 
he would have continued to see patients, might have cured 
vitiligo, and would have tinkered in his workshop forever. 
Third, Marge’s development of Alzheimer’s was devastating. 
She died at home at the age of 63, on 3 March 1987, some 
10 years after diagnosis. They had been a real team. She 
coined the term cryoglobulin and was the English professor 
associated with everything he wrote.
My siblings and I were children when we first met Millie 
Hollis. Millie came to Yale in 1957, two years after Aaron. 
She was the chief of medical nursing and associate director 
of nursing at the hospital, and would come to our house for 
Thanksgiving dinner. Aaron and Millie’s first date was a trip 
to his vacation house in Woods Hole, Massachusetts, on 1 
February 1985. They were married in 1989. Aaron actually 
knew Millie longer than he knew Marge. Millie was a con-
stant companion. No evil stepmother. She gave Aaron, and 
thus us, many extra years.
Ethan Lerner
Department of Dermatology, Harvard Medical School, Boston, 
Massachusetts, USA
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The Early Days at Yale
Early in the morning of late autumn 1955, Aaron Lerner 
entered the lobby of the New Haven Hospital and sought 
directions to the office of Paul Beeson, Chairman of 
Medicine. He had the good fortune to be recognized by a 
former medical student from the University of Michigan, now 
a medical resident, who escorted him there but advised him 
that Morning Report, a review of all admissions, would begin 
shortly. Speaking to Betty Pharr, secretary and guardian of the 
department, Aaron switched his appointment to late after-
noon because there were several things on his agenda that 
had to be settled: find a home, buy a refrigerator, establish 
accounts for utilities, telephone . . . there was not a moment 
to be lost before his evening flight back to Oregon. Things got 
done with the most efficient use of time.
This gives a glimpse not only of Aaron but also of the 
level of Yale’s preparation for his visit. He was simply the 
first dermatologist to join the department, an associate pro-
fessor appointee to head a new section of dermatology. 
Few, if any, other than Aaron would have predicted that a 
few years thence he would chair an outstanding department 
of dermatology.
In the early 1930s, a time calling for reform of medical 
education, Yale Medical School instituted a basic science/
clinical practice nexus. The department of medicine was the 
exemplar of such reform, often cited in the 1960s as best 
in the nation, notably in the areas of infectious disease and 
what was called clinical metabolism. John P. Peters chaired 
the section of metabolism—virtually a department within a 
department. Aaron referred to him as “the last great blood 
and urine scientist.” Peters was recognized as the father of 
human electrolyte physiology; he invented instruments for 
quantitative measurement and innovated the treatment of 
electrolyte imbalance to the required milliliter. His fellows 
included Franklin Epstein, Donald Seldin, and Lewis Welt.
In 1952, Paul Beeson, nationally recognized for his 
research on pyrogens and the foremost expert on “fevers 
of unknown origin,” came from Emory University to suc-
ceed Francis G. Blake as chairman of medicine. Soon after 
his arrival, the national surge in departments of medicine to 
define subspecialties caught up with him. Simple designation 
of current faculty by their individual areas of expertise and 
experience sufficed to fill most subspecialty slots. A gastroen-
terologist and an oncologist had to be recruited. An in-house 
hematologist agreed to a relatively short period of training in 
another institution to become the rheumatologist.
A similar plan was offered to an infectious disease fac-
ulty member to become the dermatologist. The offer was 
rejected with scorn, followed by his resignation and remov-
al to Johns Hopkins. There was great empathy for his deci-
sion. Dermatology lacked a respectable science base. In 
the department, clinical interest in the skin was limited to 
its manifestation of infections and disorders of other organs. 
Instruction for medical students was limited to occasions of 
observing community dermatologists quickly dispatching 
patients in a one-hour allergy/dermatology clinic.
Having known quite well Paul Beeson and Aaron 
Lerner—both of whom were quiet and tight-lipped—I feel 
certain that it was Aaron who chose Yale and not vice versa. 
In the advent of the National Institutes of Health’s generous 
funding of training programs and faculty private practice 
plans, Beeson’s departmental budget was stringent. At the 
time, the full-time faculty lived in genteel poverty. Beeson 
knew little about academic dermatologists, I feel, and it was 
unlikely that he would have known of Aaron Lerner at the 
University of Oregon. His recruitment package was modest: 
an associate professorship, a partial FTE for Marge, and a 
basement office.
Aaron, the other party in the negotiation, always knew 
precisely what he was doing. Irwin Braverman, my fellow 
companion in the early years, aptly describes Aaron as a 
born “nuts and bolts” person. Aaron had an insatiable curios-
ity about how things worked, reducing a thing to its essential 
elements and assessing the level of quality required for each 
element to work well. Aaron never trafficked in gut reactions.
Assuredly, he chose Yale because it provided an excellent 
milieu for pursuing his research, in a department that shared 
his commitment to research and that highly respected his 
research, where he would have unfettered freedom to define, 
design, and implement—on his schedule—the program of 
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the first section of dermatology. I suspect that he was confi-
dent that there would be adequate laboratory space and that 
he had a clear plan, without substantial funds, to establish a 
department of dermatology and to make research the jewel 
in the department’s crown.
In the first years, Aaron was a power of one. With borrowed 
space and equipment he began work in the lab. There were 
daily patient consultation rounds on the wards. He carefully 
selected from a broad region a few practicing dermatologists 
for voluntary service in a new dermatology clinic. He pre-
pared for the move of his laboratory and grants from Oregon 
and put together applications for approval and funding of a 
dermatology residency program. His basement office was an 
informal drop-in clinic for any medical student or house offi-
cer seeking care for themselves. One such medical student 
was Admiral Bill Narva, who remembers vividly the base-
ment office “chockful with unopened packing cases.”
I first met Aaron in that basement office in 1956. A first-
year resident in internal medicine, I had no interest in derma-
tology per se. What I sought was a placement for a mandated 
microbiological laboratory elective. Mid–medical school, I 
had dropped out to gain in 1954 a Yale PhD in microbiology, 
hence the need for a different elective. Aaron was affable and 
interested, inviting me to have an elective of tagging after him 
on the wards and in the clinic and lab.
Later, in 1957, when I arrived for the elective, it was a 
unique experience. Aaron treated me as a doctoral colleague 
and assumed that I would do the relevant self-study of der-
matology texts—which I did. In the last week of the elective, 
he invited me to be the first resident in dermatology. I had, 
through Aaron, gained a new respect for the discipline of der-
matology but not to the point of wanting to become a der-
matologist. However, I was attracted to the opportunity to be 
with Aaron and to help him in his pioneering mission. With 
Paul Beeson’s agreement and release from the medical resi-
dency, I accepted.
The following year, fellow Yalies Irwin Braverman, dis-
charged from the Army, and Joe Maguire, after equivalent 
service at the NIH, joined the residency program. Irwin 
had developed an interest in dermatology out of clinical 
necessity. For him, Aaron’s arrival at Yale during his military 
service was serendipitous; he had rejected the notion of 
doing residency training in dermatology elsewhere. In the 
early years, of all the 15 to 20 residents selected, the major-
ity pursued distinguished academic careers, mainly within 
but some outside dermatology. One, a rheumatologist, was 
a co-discoverer of Lyme disease. Another was a molecular 
science professor at MIT. I recall only two who took up pri-
vate practice.
We all shared the experience best described as being 
postdoctoral fellows rather than dermatology residents. In 
the early years, we served as surrogates in the absence of 
junior faculty, in such matters as teaching medical students 
and arranging grand rounds presentations. Given the task of 
putting together a well-received program for the first meeting 
at Yale of the New England Dermatology Society was espe-
cially satisfying. Challenging patients were to be presented 
with protocol, a dinner arranged. Aaron’s only intervention, 
arbitrary and last minute, as the invitation went to the printer, 
was to reduce the charge for an elegant dinner with cordials 
and entertainment by a Yale singing group from $5 to $4.50! 
Having budgeted it to the penny I was greatly distressed.
Because of my prior experience in managing a labora-
tory, Aaron, anxious to escape for a month at Woods Hole, 
Massachusetts, introduced me to his collaborators as being 
in charge. My first day as resident! During his first sabbatical 
year, spent at work in Cambridge, England, I was acting chair. 
Aaron’s modus operandi did not escape the attention of the 
American Board of Dermatology. A few years ago I learned 
from an ABD member that a minority of the board offered a 
resolution to censure Aaron. The motion failed, I believe, for 
two reasons: unassailable evidence of the high quality of the 
residency program and its residents and great reluctance to 
criticize the icon of basic research in dermatology.
Characteristically, Aaron never disclosed the nuts and bolts 
of his implementation of the residency program. In operating 
the new dermatology section he received the generous ser-
vices of Yale faculty in other departments, pathology, surgery, 
microbiology, and especially mycology. He designed the sec-
tion to meet fully the ABD requirements to qualify residents 
for informed, safe, and effective practice. However, an addi-
tional and more important objective was to prepare residents 
to undertake a career of basic and clinical research. Residents 
were selected who had a developed interest in research and 
the intellectual capability to pursue an academic career.
I cannot remember Aaron ever actively recruiting anyone. 
Residents in the early years stayed on to become senior fac-
ulty. Others sought out Aaron. His charisma was extremely 
subtle. He was a very quiet man, unemotional, soft-spoken, 
and never heard to criticize anyone. He shunned publicity 
and politics. We had to learn from the outside of his election 
to the National Academy of Sciences.
Michael Lerner holding hundreds of bovine pineal glands. (Photo by Alfred 
Lewy, MD, PhD.)
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Science was the center of his family life, and his fam-
ily was extensive. Included were his dear wife Marge and 
his four sons, and de facto members who had the privilege 
of working with him. Our gathering sites were exclusively 
his home in Woodbridge and the hospital. We shared the 
chores with little notice of hours and pay. Our shared goals 
were Aaron’s success in research and the development of 
an outstanding department. In modern business strategy 
terms, Aaron invested himself in human capital, the key to 
greatest success.
The integration of Aaron’s science cum family is well 
depicted in the picture of his son Michael holding hundreds 
of bovine pineal glands The picture was taken in Aaron’s 
office, with the boy standing on a chair. It was not unusual 
for the Lerner boys to come in on Sunday to wait and play 
where a huge blackboard was handy for math equations or 
chemical structures. Its ledge bore the sliding plastic chemi-
cal units of MSH being gradually identified and linked togeth-
er. When on the telephone with a colleague and competitor 
in working out the structure of MSH, Aaron heard the latest 
linkage; there was a stunned silence, he reflected, and after a 
moment, quietly showing his great respect for his colleague 
and confidence in himself, said, “Then there are two MSH’s.” 
Indeed there are: alpha and beta.
The family spirit lives on in the persons of his sons, Michael 
and Ethan, both distinguished, innovative dermatologists. The 
imprint of the family Lerner is indelible, unable to be erased 
by time and distance. The department he created and its ded-
ication to science live on as well, under the leadership of his 
successor, Rick Edelson.
In his precious free moments Aaron was a collector, filling 
his home with a historical series of calculators and gifts of 
frog memorabilia. His one public hero was Albert Einstein, 
and he had sheets of Einstein postal stamps in his collection.
Like Einstein, Aaron Lerner was an extraordinary human 
being never to be forgotten.
Marie-Louise T. Johnson
Yale University School of Medicine, New Haven, Connecticut, USA
Aaron Lerner’s Legacy at Yale University
The Yale Department of Dermatology is the “house that 
Aaron built.” That rewording of the age-old description of 
Yankee Stadium as the “house that [Babe] Ruth built” is 
quite fitting, because his most enduring legacy at Yale is the 
creation of a culture in which students, residents, fellows, 
and faculty are encouraged to “swing for the fences,” striv-
ing to follow his example of tackling big ideas and expan-
sive goals. Along with many, I have been deeply affected 
by Aaron through four decades, dating from my days as a 
Yale Medical School student performing research in the der-
matology department to my research fellowship in the der-
matology branch of the National Cancer Institute when he 
served as scientific advisor, to my faculty years at Columbia 
when he kept close watch over me, to my past 21 years as 
his successor as chair of Yale’s dermatology department. 
Running toward and then behind someone for so long, 
across all grades of terrain, gives me a cherished view of 
his comfortable gait and the giant steps that he took for and 
through the field.
Back in the late 1960s, the stampede into dermatology res-
idencies was not yet even envisioned as a national phenom-
enon but, thanks to Aaron and the faculty he had attracted, 
it was already well developed at Yale. In my 1970 graduat-
ing class alone, Len Milstone, Anne Lucky, and Rob Stern, 
in addition to myself, were stimulated to initiate our careers 
in the specialty. Aaron’s faculty in those days included four 
faculty members (himself, Irwin Braverman, Joe McGuire, 
and Marty Carter) who would each serve as president of the 
Society for Investigative Dermatology, as well as Sid Klaus, 
who would later shape Israeli dermatology as the chairman at 
Hadassah Medical Center in Jerusalem. Beyond being highly 
regarded as a center of excellence, the Yale Department of 
Dermatology was, per capita (faculty member), in the very 
top echelon of the Medical Center hierarchy.
I vividly remember being stunned by Aaron’s softly stated 
proclamation that there were still many biologically impor-
tant molecules waiting to be discovered. He thought bigger 
and with more confidence than anyone I had ever met. The 
audacity of that declaration of opportunity, emanating from 
such a soft-spoken and apparently unassuming professor, 
became indelibly imprinted on all of us. He was not only 
imploring us to shoot high and to our limits but also firmly 
admonishing us to not sell ourselves short. The accomplish-
ments of his dermatologic progeny can so readily be traced 
back to his quiet exuberance and confidence.
He inspired generations of students and faculty to think 
bold thoughts, to pursue outsized goals, to not be afraid to 
fail, and to not be afraid to swing for the fences. Swinging 
and missing then becomes a sign of strength of purpose 
and an absolute prerequisite for major success. Among the 
many, many metaphoric trees he planted in this department, 
it was his productively directed audacity that is, in my view, 
his major legacy, the one that most significantly shaped our 
department’s collective identity.
From the day that I was invited to succeed Aaron as chair, 
he was exceptionally supportive. For 10 years, from his 
maintained office, strategically placed in the midst of the 
departmental research enterprise, he provided sage coun-
sel to me on virtually all issues. He took great pride in our 
sustained growth and remained a vibrant force in our midst 
until weeks before his passing. He and his devoted wife, 
Millie, regularly attended nearly all our departmental func-
tions and honorary lectures. In early December of 2006, he 
participated in the annual holiday party, not as a guest but 
as the proud founding father of our clan.
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